Search

Author/Creator Kuroda, Hisamoto

1. Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co‐formulation therapy twice‐daily with free combination of GLP‐1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial. Issue 4 (9th November 2020)

Authors:
Aso, Yoshimasa; Takada, Yoshihisa; Tomotsune, Ken; Chiba, Yasuko; Matsumura, Mihoko; Jojima, Teruo; Sato, Minoru; Fujita, Nobuya; Kuroda, Hisamoto; Murano, Shunichi; Usui, Isao
Journal:
International journal of clinical practice
Issue:
Volume 75:Issue 4(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial (STOP‐OB). Issue 9 (7th May 2020)

Authors:
Kitazawa, Toru; Seino, Hiroaki; Ohashi, Hiroshi; Inazawa, Takeshi; Inoue, Masahiro; Ai, Masumi; Fujishiro, Midori; Kuroda, Hisamoto; Yamada, Masayo; Anai, Motonobu; Ishihara, Hisamitsu
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 9(2020)
Page Start:
1659
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of insulin degludec versus insulin glargine on glycemic control and daily fasting blood glucose variability in insulin-naïve Japanese patients with type 2 diabetes: I'D GOT trial. (August 2017)

Authors:
Aso, Yoshimasa; Suzuki, Kunihiro; Chiba, Yasuko; Sato, Minoru; Fujita, Nobuya; Takada, Yoshihisa; Murano, Shunichi; Kuroda, Hisamoto
Journal:
Diabetes research and clinical practice
Issue:
Volume 130(2017)
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗